CS/HB 833 Summary

• Expands the definition of pharmacy practice to include ordering and evaluating laboratory or clinical testing, conducting patient assessments, and initiating, modifying, discontinuing, or administering medicinal drugs pursuant to consultant pharmacist authority.

• Authorizes consultant pharmacists to provide medication management services within a collaborative practice agreement with a health care facility medical director or licensed physician, podiatric physician, or dentist authorized to prescribe drugs.

• Prohibits consultant pharmacists from modifying or discontinuing drugs prescribed by health care practitioners without a collaborative practice agreement in place.

• Requires consultant pharmacists and collaborating practitioners to maintain collaborative practice agreements that must be made available upon request or during Department of Health inspections.

• Prohibits consultant pharmacists from diagnosing any disease or condition and establishes that "health care facility" includes hospitals, surgical centers, hospices, nursing homes, and other licensed facilities.

• Effective date: July 1, 2019.